Disruption of <i>Lrpprc</i> affects B cell development and proliferation in a mouse model of Leigh Syndrome French Canadian type. [PDF]
Fois A +10 more
europepmc +1 more source
Cranial and spinal nerve enhancement in SURF1-associated Leigh syndrome. [PDF]
Dupré M +6 more
europepmc +1 more source
The California Alpha-Fetoprotein Screening Program: An Advocacy Program for Handicapped Children [PDF]
Marmion, Pat
core +1 more source
Ndufs4 inactivation in glutamatergic neurons reveals swallow-breathing discoordination in a mouse model of Leigh syndrome. [PDF]
Huff A +5 more
europepmc +1 more source
Identification of a novel pathogenic gene, NDUFA3, in Leigh Syndrome through whole exome sequencing. [PDF]
Li BG +8 more
europepmc +1 more source
Mitochondria transfer-based therapies reduce the morbidity and mortality of Leigh syndrome. [PDF]
Nakai R +14 more
europepmc +1 more source
Interferon-gamma contributes to disease progression in the Ndufs4(-/-) model of Leigh syndrome. [PDF]
Hanaford AR +15 more
europepmc +1 more source
IARS2 mutations lead to Leigh syndrome with a combined oxidative phosphorylation deficiency. [PDF]
Dong Q +12 more
europepmc +1 more source
Bi-Allelic Splicing Variant, c.153-2A > C in TOMM7 Is Associated With Leigh Syndrome. [PDF]
Yeole M +6 more
europepmc +1 more source
Synthetic aporphine alkaloids are potential therapeutics for Leigh syndrome. [PDF]
Kobayashi M +9 more
europepmc +1 more source

